2022 update to Good Publication Practice Guidelines for Company-Sponsored Biomedical Research - Volume 31, Issue

Preclinical studies - Volume 26, Issue

Welcome to this special issue about nonclinical and preclinical research. Nonclinical and preclinical research is the first step toward new drug development, where scientists investigate mechanism of action, pharmacokinetics, and safety. Many…

Non-clinical health writing - Volume 23, Issue

We medical writers have a unique and valuable skill set, which includes, most notably, the ability to understand and clearly communicate complex medical information. We are also experts at working with multifunctional teams, compiling detailed…

Transparency and public disclosure: What climate research can learn from clinical research – and vice versa - Volume 31, Issue

The healthcare industry is spearheading initiatives for public disclosure, open access, and plain language summaries in biomedical research. These initiatives are being mirrored in other fields of research as well, including climate research. Below…

Pesticide dossiers, an opportunity for medical writers - Volume 23, Issue

Pesticides, also known as crop protection products, are approved for sale through a process similar to that for authorising human medicines. For example, the toxicology data submitted are nearly identical to the nonclinical data generated for a…

Introduction - Volume 28, Issue

It is my privilege to present you the Medical Writing special issue garnering the current Trends in the Medical Writing sphere. With the perpetual amendments in the pharmaceutical industry and the ever-evolving approaches in operating and…

EMWA News - Volume 30, Issue

In September 2021, the editors-in-chief of over 200 biomedical and scientific journals from all geographic regions issued a call for Emergency Action to Limit Global Temperature Increases, Restore Biodiversity, and Protect Health.1 This editorial…

From the Editor - A call to action - Volume 31, Issue

In September 2021, more than 200 biomedical and scientific journals simultaneously published an editorial that called for “Emergency Action to Limit Global Temperature Increases, Restore Biodiversity, and Protect Health.” MEW, with the endorsement…

Scientific advice procedures in the EU – an overview ofthe regulatory background - Volume 29, Issue

The prerequisite for obtaining marketing authorisation is an appropriate and robust data package that demonstrates a medicinal product’s quality and its efficacy and safety in the proposed indication. Pharmaceutical companies can face regulatory…

What can twitter do for me? - Volume 22, Issue

Like everything, the usefulness of twitter depends on what the user does with it. Here is an assortment of information that can be obtained if you selectively follow organisations with twitter accounts relevant to your interests or…